This tech millionaire went from covid trial funder to misinformation superspreader
After boosting unproven covid drugs and campaigning against vaccines, Steve Kirsch was abandoned by his team of scientific advisers—and left out of a job.
After boosting unproven covid drugs and campaigning against vaccines, Steve Kirsch was abandoned by his team of scientific advisers—and left out of a job.
Even as the president was rushed to the hospital at Walter Reed, for what the White House said would be days of observation, rest, and testing, officials inside the administration said they didn’t anticipate much of a shake-up in their approach to combating COVID. There would reportedly be no official revised mask policy, which remained encouraged but not required.
These days in Korea, TV broadcasters talk about the U.S. with grim faces, flashing to B-roll of lines of Americans wrapped around buildings waiting for Covid-19 testing or graphs depicting an exponential growth of pandemic deaths. Newspaper headlines question the strength of U.S. democracy above pictures of demonstrators protesting mythical claims of voter fraud.
On any given month before the pandemic, volunteers and staff would distribute food to as many as 300,000 people. With the coronavirus pandemic continuing to wreak economic devastation across the United States, that number has tripled.
Should medical journals enter the political realm?
Gov. Andrew Cuomo on Sunday vowed a robust vaccination distribution plan in New York amid a dispute with the Trump administration over how to do so, while also raising concerns the state needs the resources for the undertaking in the coming weeks.
With a third surge of the Covid-19 pandemic hitting the U.S., many public-health authorities are warning the coronavirus is now so widespread that it will take pervasive new measures to contain it.
At the height of the pandemic, the city issued $1.4 billion in emergency, no-bid contracts for crucial medical equipment — and got the wrong masks and lost track of deliveries, records show.
The plan and the board members who will implement it are mostly to be celebrated. Still, both create cause for concern, particularly in regard to how incarceration, health care access and the persuasive (and bipartisan) ideology of ableism have plagued so much of the coronavirus response in the United States.
The drug maker Pfizer announced on Monday that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19, a promising development as the world has waited anxiously for any positive news about a pandemic that has killed more than 1.2 million people.